• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7321
Device Problem Unsealed Device Packaging (1444)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 09/09/2017
Event Type  Injury  
Event Description
Advocate from (b)(6) stated her daughter fell asleep and at 9:30 pm when she took her to bed, she realized she was very weak and would not wake up.According to her contour next link log book her blood glucose readings at 9:20 and 9:23 pm were 6.6 and 7.2 mmol/l.She was very sick and had hypoglycemic symptoms.Advocate took her to the hospital where she was given iv dextrose.At 11:02 pm her blood glucose on the contour next link was 7.5.She was retested on the hospital meter and the reading was 2.2 mmol/l.At 12:04 the patient was tested on the hospital meter and her reading was 14.8 mmol/l.The difference between the readings falls in the "d" zone of the consensus error grid, making the difference clinically significant.The advocate was advised to return the strips for evaluation.A new meter was sent to the customer.
 
Manufacturer Narrative
The returned test strips were tested using blood targeted to 3.7 mmol/l and 7.4 mmol/l as determined by a ysi glucose analyzer.All returned test strip results with blood were high outside of the ffu limits.The returned test strips were also tested on an in-house contour xt (thp) meter using blood targeted to 67 mg/dl and 134 mg/dl as determined by a ysi glucose analyzer.All thp meter and returned test strip results with blood were also high outside of the ffu limits.The returned meter and in-house retained contour next strips (lot# dw6jfec31f) were also tested using blood targeted to 3.7 mmol/l and 7.4 mmol/l as determined by a ysi glucose analyzer.All results with in-house retained test strips were within the ffu limits.No high results were observed with the in-house retained test strips.The event is confirmed for high results with the returned strips, however the in-house retained test strips of the same lot gave acceptable performance.It is likely that the returned test strips were not stored properly by the customer and were exposed to a contaminant that caused the high results.Strips returned for evaluation have different lot# than those in the initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Type of Device
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
430 s beiger st
mishawaka IN 46544
Manufacturer (Section G)
ASCENSIA DIABETES CARE US INC
430 s beiger st
mishawaka IN 46544
Manufacturer Contact
jeri messmore
430 s beiger st
mishawaka, IN 46544
5743149617
MDR Report Key6921606
MDR Text Key88406532
Report Number1826988-2017-00309
Device Sequence Number1
Product Code NBW
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K110894
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date 09/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/30/2018
Device Model Number7321
Device Lot Number6JFEC31F
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/11/2017
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/11/2017
Initial Date FDA Received10/06/2017
Supplement Dates Manufacturer Received12/11/2017
Supplement Dates FDA Received01/04/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/01/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-